“Hawai‘i is on the front line for antibiotic-resistant gonorrhea – we’ve been one of the first states to see declining effectiveness of each drug over the years,” said Alan Katz, MD, MPH, professor of public health at the University of Hawai‘i, member of the Hawaii State Board of Health, and staff physician and medical consultant at the Hawaii State Department of Health’s Diamond Head STD Clinic. “That’s made us extremely vigilant, so we were able to catch this cluster early and treat everyone found who was linked to the cluster. But the future risk of gonorrhea becoming resistant to both of the recommended therapy medications in the United States is troubling.”